CC
Casdin Capital Portfolio holdings
AUM
$1.1B
This Quarter Return
-22.52%
1 Year Return
+24.98%
3 Year Return
+152.8%
5 Year Return
+110.01%
10 Year Return
–
AUM
$1.18B
AUM Growth
+$1.18B
(-47%)
Cap. Flow
-$448M
Cap. Flow
% of AUM
-37.88%
Top 10 Holdings %
Top 10 Hldgs %
68.01%
Holding
52
New
5
Increased
2
Reduced
19
Closed
12
Top Buys
| 1 |
GeneDx Holdings
WGS
|
$14.4M |
| 2 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
$10.8M |
| 3 |
AbCellera Biologics
ABCL
|
$7.99M |
| 4 |
Celldex Therapeutics
CLDX
|
$4.45M |
| 5 |
PMV Pharmaceuticals
PMVP
|
$4.28M |
Top Sells
| 1 |
Pacific Biosciences
PACB
|
$72.7M |
| 2 |
CareDx
CDNA
|
$42.7M |
| 3 |
Exact Sciences
EXAS
|
$34.7M |
| 4 |
Fate Therapeutics
FATE
|
$32.2M |
| 5 |
Agios Pharmaceuticals
AGIO
|
$28.9M |
Sector Composition
| 1 | Healthcare | 99.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
EQRX
1
DELISTED
EQRx, Inc. Common Stock
EQRX
| $185M | 15.67% | 39,527,669 | – | – |
|
2
Alnylam Pharmaceuticals
ALNY
$58.5B
| $117M | 9.93% | 805,000 -195,000 | -20% | -$28.4M |
|
3
BioLife Solutions
BLFS
$1.2B
| $104M | 8.83% | 7,566,292 | – | – |
|
4
Relay Therapeutics
RLAY
$619M
| $68.1M | 5.76% | 4,068,574 +211,321 | +5% | +$3.54M |
|
5
MaxCyte
MXCT
$148M
| $66.1M | 5.59% | 13,971,334 | – | – |
|
|
BPMC
6
DELISTED
Blueprint Medicines
BPMC
| $58.1M | 4.91% | 1,150,000 -400,000 | -26% | -$20.2M |
|
|
SLGC
7
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
| $56M | 4.73% | 12,389,082 | – | – |
|
|
8
Fate Therapeutics
FATE
$120M
| $52M | 4.4% | 2,100,000 -1,300,000 | -38% | -$32.2M |
|
9
Sarepta Therapeutics
SRPT
$1.78B
| $48.7M | 4.12% | 650,000 -150,000 | -19% | -$11.2M |
|
|
VERV
10
DELISTED
Verve Therapeutics
VERV
| $48M | 4.05% | 3,138,167 | – | – |
|
11
Revolution Medicines
RVMD
$7.1B
| $46.2M | 3.91% | 2,370,000 | – | – |
|
12
Denali Therapeutics
DNLI
$2.23B
| $44.1M | 3.73% | 1,500,000 | – | – |
|
13
Century Therapeutics
IPSC
$42.5M
| $26.9M | 2.28% | 3,206,380 | – | – |
|
14
Absci
ABSI
$357M
| $25.6M | 2.17% | 7,718,593 | – | – |
|
|
GBT
15
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $25.6M | 2.16% | 800,000 -525,000 | -40% | -$16.8M |
|
|
16
GeneDx Holdings
WGS
$3.72B
| $20.7M | 1.75% | 16,437,500 +11,437,500 | +229% | +$14.4M |
|
17
Tenaya Therapeutics
TNYA
$184M
| $20.2M | 1.71% | 3,586,818 | – | – |
|
|
18
Exact Sciences
EXAS
$8.98B
| $17.7M | 1.5% | 450,000 -880,000 | -66% | -$34.7M |
|
19
Twist Bioscience
TWST
$1.63B
| $17.5M | 1.48% | 500,000 -380,000 | -43% | -$13.3M |
|
|
20
Agios Pharmaceuticals
AGIO
$2.19B
| $17.4M | 1.47% | 785,000 -1,305,000 | -62% | -$28.9M |
|
21
Tango Therapeutics
TNGX
$747M
| $15.9M | 1.34% | 3,500,000 -1,987,910 | -36% | -$9.01M |
|
22
Beam Therapeutics
BEAM
$1.66B
| $14.5M | 1.23% | 375,000 -443,820 | -54% | -$17.2M |
|
23
Guardant Health
GH
$8.41B
| $11M | 0.93% | 272,500 -147,500 | -35% | -$5.95M |
|
|
KRTX
24
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $10.8M | 0.91% | +85,000 | New | +$10.8M |
|
|
TSVT
25
DELISTED
2seventy bio
TSVT
| $8.12M | 0.69% | 614,754 | – | – |
|